FDA product code CKH: Acid Phosphatase, Beta Glycerophosphate
CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel. Devices under CKH reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for CKH devices.
Classification
| Field | Value |
|---|---|
| Device name | Acid Phosphatase, Beta Glycerophosphate |
| Device class | Class II |
| Regulation | 21 CFR 862.1020 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for CKH devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2004-08-20.
Frequently asked questions
What is FDA product code CKH?
CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel.
What device class is CKH?
Class II, regulation 21 CFR 862.1020. Typical premarket route: 510(k) exempt.
Have CKH devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2004-08-20.
Next steps
- Run an FDA pathway report with predicate devices for product code CKH
- Run a recall and safety report across every CKH manufacturer
- Watch product code CKH for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times